Profil
Drew A. Hoffmann is a former Chief Executive Officer at Synvascular, Inc., President & Chief Executive Officer at Nanostim, Inc., Chief Executive Officer at INSPIRATION Medical GmbH, and Executive-in-Residence at Interwest Venture Management Co. He holds a doctorate degree from Stanford University.
Anciens postes connus de Drew A. Hoffmann
| Sociétés | Poste | Fin |
|---|---|---|
Nanostim, Inc.
Nanostim, Inc. Medical SpecialtiesHealth Technology Develops cardiac pacemakers | Directeur Général | - |
INSPIRATION Medical GmbH
INSPIRATION Medical GmbH Medical SpecialtiesHealth Technology Manufactures medical devices for the treatment of sleep apnea | President | - |
Interwest Venture Management Co.
Interwest Venture Management Co. Investment ManagersFinance InterWest Venture invests in companies located in the United States. The firm focuses on healthcare and information technology. It participates in early stage transactions. It also acts as a lead investor and takes a seat on the board. | Consultant / Advisor | - |
Synvascular, Inc.
Synvascular, Inc. Medical SpecialtiesHealth Technology Designs, develops, and markets medical devices | President | - |
Formation de Drew A. Hoffmann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Synvascular, Inc.
Synvascular, Inc. Medical SpecialtiesHealth Technology Designs, develops, and markets medical devices | Health Technology |
Nanostim, Inc.
Nanostim, Inc. Medical SpecialtiesHealth Technology Develops cardiac pacemakers | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INSPIRATION Medical GmbH
INSPIRATION Medical GmbH Medical SpecialtiesHealth Technology Manufactures medical devices for the treatment of sleep apnea | Health Technology |
Interwest Venture Management Co.
Interwest Venture Management Co. Investment ManagersFinance InterWest Venture invests in companies located in the United States. The firm focuses on healthcare and information technology. It participates in early stage transactions. It also acts as a lead investor and takes a seat on the board. | Finance |
















